E
Endovascular Engineering
Vascular thrombectomy solutions enhancing patient outcomes through innovative medical devices
About Endovascular Engineering
Endovascular Engineering is a venture-funded medical device startup in stealth mode, focused on developing advanced vascular thrombectomy solutions. These devices are designed to remove blood clots from blood vessels, thereby improving patient outcomes in critical medical situations. The company operates in the medical technology market, primarily serving healthcare providers such as hospitals and clinics that require cutting-edge tools for vascular procedures. Endovascular Engineering's business model revolves around the research, development, and eventual commercialization of these medical devices. Revenue is generated through the sale of these devices to healthcare institutions and potentially through partnerships or licensing agreements with larger medical technology firms. The company is based in Menlo Park, California, and is actively seeking talented and passionate individuals to join their team.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2019
- Headquarters
- Menlo Park, United States
- Employees
- 41
- Open positions
- None listed
- Dealroom signal
- 89.9/100
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- Health Tech & Medtech, Surgery, Cardiology and cardiovascular, Catheters, Spinout, DT and LS, science-based
- Technology
- Deep Tech
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES COther financing | Apr 2026 | $80M | $320M | Panakès Partners · Gilde Healthcare · Norwest Venture Partners · S3 Ventures | ↗ |
| SERIES BOther financing | Feb 2025 | $42M | $168M | Panakès Partners · M&L Group · Sante Ventures · S3 Ventures | ↗ |
Growth signals
Latest recorded traffic for Endovascular Engineering is 850 monthly website visits, down 66% over the last three months. Endovascular Engineering's team grew 10.8% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A6 investors entered at this stage
Cordis
Sante Ventures
S3 Ventures
415 Capital
Panakès Partners
M&L Group
Series B and later3 investors entered at this stage
Gilde Healthcare
Norwest Venture Partners- MIM&L Healthcare Investments
Other known investors1 additional known investor
University of Michigan
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Endovascular Engineering on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Endovascular Engineering’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.